carcinogenicity is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-02-16. Numbers and descriptions here follow the published literature rather than marketing material.
Cardarine is a common name for GW501516, a synthetic compound first described in the 1990s as a selective agonist of the peroxisome proliferator-activated receptor delta. It was studied in preclinical models for metabolic and cardiovascular conditions, but it has not been approved as a medicine in the United States, Europe, or other major jurisdictions. Retail products labeled as cardarine are generally research chemicals or supplements, not pharmaceutical formulations. Because human safety and efficacy data remain limited, regulatory agencies treat it as an unapproved substance rather than a therapeutic product.
Sporting authorities added GW501516 to prohibited lists after it appeared in athlete samples and online markets. The World Anti-Doping Agency classifies it as a hormone and metabolic modulator, and its use can lead to an anti-doping rule violation. Some early laboratory work suggested effects on fatty acid oxidation and endurance-related metabolism in animals, but those findings do not establish safe or effective use in people. Reports of adverse events in humans are scarce and often anecdotal, which complicates risk assessment.
Laboratory studies indicate that GW501516 activates PPARδ, a nuclear receptor involved in fatty acid oxidation and energy metabolism. In rodent experiments, treated animals often showed increased endurance and reduced fat mass. These effects were observed under controlled conditions and do not establish safe or effective use in humans. The exact dose-response relationship in humans remains poorly characterized. Species differences in metabolism can affect how results translate across animals and people.
Safety concerns emerged from long-term animal studies. In rodents given the compound for extended periods, researchers found an increased incidence of certain cancers, including liver and bladder tumors. These findings contributed to the discontinuation of clinical development. Whether similar risks apply to short-term or low-level exposure in humans is not established, and controlled human safety data are limited. The relevance of high-dose rodent carcinogenicity findings to human use remains a subject of debate.
Human trials of GW501516 were small and short in duration. They examined lipid levels, glucose handling, and other metabolic markers, but the programs were halted after the animal cancer findings. No approved therapeutic product exists, and published human data are insufficient for establishing long-term safety. Reports of use for athletic performance come mainly from non-clinical settings and cannot be verified through controlled trials. Independent testing of products sold as cardarine has found inconsistent purity and labeling.
| Property | Value | Notes |
|---|---|---|
| IUPAC name | {4-[({4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl}methyl)sulfanyl]phenoxy}acetic acid | Systematic name for GW501516 |
| CAS Registry Number | 317318-70-0 | Unique identifier for the parent compound |
| Molecular formula | C21H18F3NO3S2 | Includes carbon, hydrogen, fluorine, nitrogen, oxygen, and sulfur |
| Molecular weight | 453.5 g/mol | Approximate value for the neutral form |
| Appearance | White to off-white powder | Typical description for purified laboratory material |
Cardarine has no approved therapeutic indication and is not marketed as a medicine. The World Anti-Doping Agency lists GW501516 as a prohibited substance at all times, covering both in-competition and out-of-competition periods. National laws vary: some countries treat it as an unapproved drug subject to import controls, while others have specific restrictions on sale for human consumption. It is often sold as a research chemical, a label that does not imply safety or legality. Enforcement actions have targeted online vendors and shipments.
Anti-doping laboratories identify GW501516 and related metabolites using liquid chromatography coupled with tandem mass spectrometry. Urine is the most common matrix, though blood and dried blood spots may also be analyzed. The method targets the parent compound and phase I and phase II metabolites, which extend the detection window. Because the substance is prohibited at all times, athletes can be tested outside competition. Detection limits and windows depend on the assay, sample type, and individual metabolism.
Cardarine is the common name for GW501516, a synthetic compound studied as a peroxisome proliferator-activated receptor delta agonist. Researchers developed it to explore treatments for lipid disorders and metabolic conditions. It is not an approved medicine in any country. Early clinical work examined changes in HDL cholesterol and triglycerides, but development was discontinued after animal studies raised concerns about cancer. The compound remains available as a research chemical and appears in discussions of performance enhancement.
At the molecular level, GW501516 binds and activates PPARδ, a nuclear receptor that regulates transcription. Activation shifts expression of genes involved in fatty acid oxidation, energy expenditure, and lipid transport in skeletal muscle and liver. Animal studies report increased endurance and altered lipid profiles after exposure. Human data are limited to small trials and do not establish long-term safety or efficacy. PPARδ also has roles in cell proliferation, so the relationship between activation and cancer risk remains an open question.
GW501516 acts as a ligand for PPAR delta, a nuclear receptor that regulates transcription of genes involved in fatty acid oxidation and energy use. Activation of this receptor in skeletal muscle shifts metabolism toward fat burning in animal models. The compound does not burn fat directly; it changes gene expression over hours to days. Researchers study it to understand metabolic flexibility and exercise adaptation. Effects observed in rodents are not automatically expected in humans.
Preclinical research reported that GW501516 increased running endurance in mice and improved lipid profiles in some animal species. Early human trials explored effects on high-density lipoprotein cholesterol, triglycerides, and glucose handling, but the program was discontinued. Published human data are sparse and do not establish efficacy for any condition. Studies also examined PPAR delta in cancer biology, with conflicting findings across models. The relationship between receptor activation, tissue context, and disease risk remains an active area of investigation.
Analytical laboratories typically identify cardarine and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is a common matrix in anti-doping testing, while blood and tissue may be used in research settings. Detection windows depend on the assay, the sample matrix, and the compound's metabolism. Because cardarine is extensively metabolized, laboratories often target specific metabolites to improve sensitivity and confirmation. Reference standards are required for reliable quantification. Method validation includes checks for selectivity, linearity, and carryover.
A persistent misconception is that cardarine is a fat-burning drug or a safe alternative to anabolic steroids. No approved therapeutic product exists, and human safety data are limited. The tumor findings in rodents remain a central concern in scientific reviews. Products sold online may contain inaccurate labels, impurities, or different compounds entirely, which complicates any assessment of effects. Independent testing of such products has reported frequent mislabeling. For these reasons, discussions in the literature emphasize risks and unknowns rather than benefits.
Tourism is a significant contributor to the Romanian economy, generating around 5% of GDP. The number of tourists has been rising steadily, reaching 9.33 million foreign tourists in 2016, according to the Worldbank. Tourism in Romania attracted €400 million in investments in 2005. More than 60% of the foreign visitors in 2007 were from other EU countries. The popular summer attractions of Mamaia and other Black Sea Resorts attracted 1.3 million tourists in 2009. Among Romania's spa towns and resorts are Buziaș, Băile Călacea, Moneasa, Băile Lipova, Călimănești, Amara, and Geoagiu-Băi. At the same time, seaside resorts such as Eforie, Mangalia, Saturn, Venus, Neptun, Olimp, and Mamaia (sometimes also called the Romanian Riviera) are among the main tourist attractions during the summer. Most popular skiing resorts are along the Valea Prahovei, Muntele Mic, Semenic, Straja and Poiana Brașov. Wine tourism is represented by areas such as Recaș, Silagiu, Odobești, Drăgășani, and Podgoria Aradului. Castles, fortifications, or strongholds as well as preserved medieval Transylvanian cities or towns such as Timișoara, Cluj-Napoca, Sibiu, Brașov, Alba Iulia, Baia Mare, Bistrița, Mediaș, Cisnădie, Sebeș, or Sighișoara also attract a large number of tourists. Bran Castle, near Brașov, is one of the most famous attractions in Romania, drawing hundreds of thousands of tourists every year as it is often (falsely) advertised as being Dracula's Castle. Other attractions include the Danube Delta or the Sculptural Ensemble of Constantin Brâncuși at Târgu Jiu.
==== Prostacyclin ==== Prostacyclin (PGI2) is released by endothelium and activates platelet Gs protein-linked receptors. This, in turn, activates adenylyl cyclase, which synthesizes cAMP. cAMP inhibits platelet activation by decreasing cytosolic levels of calcium and, by doing so, inhibits the release of granules that would lead to activation of additional platelets and the coagulation cascade.
Tylosin is a macrolide antibiotic and bacteriostatic feed additive used in veterinary medicine. It has a broad spectrum of activity against Gram-positive organisms and a limited range of Gram-negative organisms. It is found naturally as a fermentation product of Streptomyces fradiae. Tylosin is used in veterinary medicine to treat bacterial infections in a wide range of species and has a high margin of safety. It has also been used as a growth promotant in some species, and as a treatment for colitis in companion animals.
Sources: en.wikipedia.org
==== 2200–2299 ==== Motor Vehicles (Type Approval for Goods Vehicles) (Great Britain) (Amendment) Regulations 1993 (S.I. 1993/2200) Motor Vehicles (Type Approval) (Great Britain) (Amendment) Regulations 1993 (S.I. 1993/2201) Bananas (Interim Measures) (Revocation) Regulations 1993 (S.I. 1993/2204) Wireless Telegraphy (Television Licence Fees) (Amendment) (No. 2) Regulations 1993 (S.I. 1993/2205) National Health Service (General Dental Services) Amendment Regulations 1993 (S.I. 1993/2209) Dental Vocational Training Authority Regulations 1993 (S.I. 1993/2210) Dental Vocational Training Authority (Establishment and Constitution) and Appeal Body (Specification) Order 1993 (S.I. 1993/2211) Taxes (Interest Rate) (Amendment No. 3) Regulations 1993 (S.I. 1993/2212) Friendly Societies Act 1992 (Commencement No. 6 and Transitional Provisions) Order 1993 (S.I. 1993/2213) Finance Act 1993 (Appointed Day) Order 1993 (S.I. 1993/2214) Finance Act 1993, section 12, (Appointed Day) Order 1993 (S.I. 1993/2215) National Health Service (District Health Authorities) (No.2) Order 1993 (S.I. 1993/2218) National Health Service (Determination of Districts) (No.2) Order 1993 (S.I. 1993/2219) National Health Service (General Dental Services) (Scotland) Amendment Regulations 1993 (S.I. 1993/2224) Parole Board (Scotland) Rules 1993 (S.I. 1993/2225) Transcripts of Criminal Proceedings (Scotland) Order 1993 (S.I. 1993/2226) Prison (Scotland) Amendment Rules 1993 (S.I. 1993/2227) Young Offenders (Scotland) Amendment Rules 1993 (S.I. 1993/2228) Road Traffic Act 1991 (Commencement No.
Biological activities of metal ion-binding compounds can be changed in response to the increment of the metal concentration, and based on the latter compounds can be classified as "metal ionophores", "metal chelators" or "metal shuttles". If the biological effect is augmented by increasing the metal concentration, it is classified as a "metal ionophore". If the biological effect is decreased or reversed by increasing the metal concentration, it is classified as a "metal chelator". If the biological effect is not affected by increasing the metal concentration, and the compound-metal complex enters the cell, it is classified as a "metal shuttle". The term ionophore (from Greek ion carrier or ion bearer) was proposed by Berton Pressman in 1967 when he and his colleagues were investigating the antibiotic mechanisms of valinomycin and nigericin. Many ionophores are produced naturally by a variety of microbes, fungi and plants, and act as a defense against competing or pathogenic species. Multiple synthetic membrane-spanning ionophores have also been synthesized. The two broad classifications of ionophores synthesized by microorganisms are:
Raleigh ( RAH-lee) is the capital city of the U.S. state of North Carolina. It is the second-most populous city in the state (after Charlotte), tenth most populous city in the Southeast, the largest city in the Research Triangle area, and the 39th-most populous city in the U.S. Known as the "City of Oaks" for its oak-lined streets, Raleigh covers 148.54 square miles (384.7 km2) and had a population of 467,665 at the 2020 census. It is the county seat of Wake County and is named after Sir Walter Raleigh, who founded the lost Roanoke Colony. Raleigh is home to North Carolina State University and is part of the Research Triangle, which includes Durham (home to Duke University and North Carolina Central University) and Chapel Hill (home to the University of North Carolina at Chapel Hill). The Research Triangle area, centered around Research Triangle Park, has a population of over 2.37 million people. The Raleigh–Cary metropolitan statistical area alone has an estimated population of 1.51 million. Raleigh lies primarily in Wake County, with a small portion of the city extending into Durham County. Nearby suburbs include Apex, Cary, Clayton, Fuquay-Varina, Garner, Holly Springs, Knightdale, Morrisville, Rolesville, Wake Forest, Wendell, and Zebulon. Raleigh is an early example in the United States of a planned city. Following the American Revolutionary War when the U.S. gained independence, the area was chosen as the site of the state capital in 1788 and incorporated in 1792 as such.
Sources: en.wikipedia.org
No. Major drug regulators have not approved GW501516 for treating any medical condition. Products sold as cardarine are typically unapproved research chemicals or supplements, so their contents and safety are not assured.
It is prohibited by the World Anti-Doping Agency as a hormone and metabolic modulator. Athletes who test positive for GW501516 can face sanctions, including suspensions and loss of results.
Cardarine is a common or trade-style name, while GW501516 is the research code for the same chemical entity. Some sources also use Endurobol or GSK-516. The names refer to the same compound, not distinct drugs.
Rodent studies reported increased endurance and fat oxidation after GW501516 exposure. Long-term studies also found higher rates of some tumors, which led to halted development.